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Abstract
Prion diseases are fatal neurodegenerative disorders caused by an aberrant accumulation of the misfolded cellular prion
protein (PrPC) conformer, denoted as infectious scrapie isoform or PrPSc. In inherited human prion diseases, mutations in the
open reading frame of the PrP gene (PRNP) are hypothesized to favor spontaneous generation of PrPSc in specific brain
regions leading to neuronal cell degeneration and death. Here, we describe the NMR solution structure of the truncated
recombinant human PrP from residue 90 to 231 carrying the Q212P mutation, which is believed to cause Gerstmann-
Stra¨ussler-Scheinker (GSS) syndrome, a familial prion disease. The secondary structure of the Q212P mutant consists of a
flexible disordered tail (residues 90–124) and a globular domain (residues 125–231). The substitution of a glutamine by a
proline at the position 212 introduces novel structural differences in comparison to the known wild-type PrP structures. The
most remarkable differences involve the C-terminal end of the protein and the b2–a2 loop region. This structure might
provide new insights into the early events of conformational transition of PrPC into PrPSc. Indeed, the spontaneous
formation of prions in familial cases might be due to the disruptions of the hydrophobic core consisting of b2–a2 loop and
a3 helix.
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Introduction
Transmissible spongiform encephalopathies (TSE), or prion
diseases, are a rare group of neuropathies characterized by a
spongiform neurodegeneration of the brain caused by prions.
Amyloid deposits may parallel the pathology and are mainly
composed by the abnormal, misfolded form of the cellular prion
protein (PrPC) denominated PrPSc. The unique etiology of this
group of maladies can be sporadic, inherited and iatrogenic [1].
These disorders include Creutzfeldt–Jakob disease (CJD), Gerst-
mann-Stra¨ussler-Scheinker (GSS) syndrome, Fatal Familial In-
somnia (FFI) and kuru in humans, bovine spongiform encephalo-
pathy in cattle, scrapie in sheep, and chronic wasting disease in elk,
deer and moose.
The human (Hu) PrPC is a 209 residues glycoprotein, attached
by a C-terminal glycosylphosphatidylinositol to the outer leaflet of
plasma membrane of the cell and is highly conserved among
mammals. Although several processes in the nervous system are
influenced by PrPC, its physiological function still remains elusive
[2]. According to the ‘‘protein-only hypothesis’’, in prion disease
PrPC is converted into the abnormal type by a conversion process
whereby most a-helix motives are replaced by b-sheet secondary
structures [3]. The PrPC to PrPSc conversion leads to altered
biochemical properties, such as resistance to limited proteolysis
and insolubility in non-denaturant detergents [4,5].
Although the molecular mechanisms leading to the disease are
still controversial, many evidences suggest that the generation of
prion disease is dependent only on PrPC. Mice devoid of PrPC are
resistant to scrapie, and the reintroduction of the PrP gene (Prnp in
mice) restores TSE susceptibility [6,7]. Moreover, amyloid PrP
fibrils generated in vitro induced prion disease in transgenic mice
overexpressing PrP, which was subsequently transmissible to wild-
type (WT) mice [8,9].
One of the strongest arguments supporting the ‘‘protein-only
hypothesis’’ is the link between inherited prion diseases and
mutations in the PRNP gene. Several point mutations leading to
familial CJD, GSS or FFI have been identified in the open reading
frame of the PRNP gene [10]. Transgenic mice carrying
pathological PrP mutations develop a spectrum of neurological
diseases sharing some features with TSE [11,12,13,14]. Our
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understanding of the mechanisms by which mutations induce the
disease still remains limited. Mutations may increase the likelihood
of misfolding by the thermodynamic destabilization of PrPC
[15,16,17,18]. PrP mutants may escape quality control cellular
pathway and accumulate inside the cell [19,20,21,22]. In addition,
mutations may change surface properties promoting an abnormal
Figure 1. NMR spectra and assignment of HuPrP(90–231, M129, Q212P). (A) 1H-15N HSQC spectrum with one letter amino acid code. (B)
Backbone assignment for the part that shows unique structural features. Strips for residues 221-230 from 3D CA(CO)NH and HNCA experiments with
cross-peaks in black from 13Ca(i-1) nuclei in CA(CO)NH experiment and in red corresponding to
13Ca(i-1) and
13Ca(i) nuclei revealed by HNCA
experiment. Blue line indicates sequential walk.
doi:10.1371/journal.pone.0011715.g001
Figure 2. High-resolution structure of HuPrP(90–231, M129, Q212P). (A) Cartoon representation of the lowest energy structure on the van
der Waals surface. (B) Sequence of HuPrP(90–231, M129, Q212P) protein. The elements of secondary structure are shown. (C) Structural details of a3
helix in the family of 20 lowest energy structures from Met205 to Arg220 in the Q212P mutant (left, pdb id 2KUN) and WT HuPrPC (right, pdb id
1QM1) [25]. Residues Pro212 and Gln212 are presented in pink. The r.m.s.d. for backbone atoms in residues between Met205 and Arg220 in both
ensembles is 0.7 A˚.
doi:10.1371/journal.pone.0011715.g002
Mol. Basis of Prion Disease
PLoS ONE | www.plosone.org 3 July 2010 | Volume 5 | Issue 7 | e11715
interaction between PrPC and other not yet identified interactors
[23,24].
NMR studies of recombinant HuPrP(90–231) reveal a structure
containing a short flexible chain at the C-terminal, a globular
domain with three alpha helices (a1, a2 and a3), a short anti-
parallel beta sheet (b1 and b2), and an unstructured N-terminal tail
[25,26]. Up to date, there is no evidence showing that a
pathological point mutation may cause substantial structural
differences in the PrP fold. Indeed, solution structures of some
pathogenic HuPrP mutants exhibit conformations similar to the
WT protein [27,28].
To provide new clues on the role of pathological point
mutations on PrP structure, in this study we determined and
examined a high-resolution 3D structure of the truncated
recombinant HuPrP(90–231) containing the pathological Q212P
mutation. This mutation is responsible for a GSS syndrome
characterized by mild amyloid PrP deposition in patients [29,30].
Subsequently, we compared our structural findings with the
already resolved NMR structures of HuPrP carrying the CJD-
related E200K [28] and the artificial R220K mutations [31]. The
substitution of a glutamine by a proline at the position 212
revealed novel and unique structural differences in comparison to
the known structures of either human or other mammalian PrPC
[32,33,34,35,36].
Results
Location and nature of mutation at codon 212
The Q212P mutation in PrPC is associated with GSS, a slowly
progressive hereditary autosomal dominant disease. Interestingly,
neuro-pathological examination of CNS of patients with this
disorder showed mild amyloid PrP deposition, and the disease
presented reduced penetrance among relatives [29,30]. The
hallmark of the GSS neuropathology is the encephalo(myelo)pathy
with multi-centric PrP plaques [37]. Epidemiologic data of GSS
are difficult to estimate, but figures within the range of 1–10/
100,000,000 are quoted [38,39]. Amongst the inherited prion
diseases, Q212P is a very rare point mutation: only one family case
carrying this mutation has been described. Gln212 is highly
conserved among mammalian and non-mammalian PrP [40].
This amino acid residue is located in the middle of a3 helix in close
proximity to the disulfide bond Cys179 – Cys214 and forms a
hydrogen bond with Thr216 [41].
Sequence-specific resonance assignment of HuPrP
(90–231, M129, Q212P)
1H-15N HSQC spectrum of 13C, 15N double labeled mutant
demonstrated good dispersion of amide signals (Figure 1A). Cross-
peaks for all residues could be identified with the exception of
Arg164, Tyr169, Asn171, Phe175 and Gln217, which were not
observed due to line broadening caused by exchange processes (see
below). The sequence-specific assignment was achieved with the use
of standard triple resonance HNCA, HN(CO)CA, HNCACB and
CBCA(CO)NH NMR experiments. Strips from 3D CA(CO)NH
and HNCA experiments in Figure 1B illustrate sequential walk in
the region from Glu221 to Ser230. The assignment was additionally
confirmed by analysis of sequential and medium-range NOEs in 3D
15N-edited NOESY-HSQC experiment. 1H and 13C resonances of
side chains were assigned by analyses of 3D (H)CCH-TOCSY and
13C-edited NOESY-HSQC spectra. Final level of completeness of
1H, 13C and 15N resonance assignment was very high (95.1%).
Chemical shifts were deposited in BioMagnetic Resonance data
Bank (BMRB, accession code 16743).
The Cb chemical shifts of Cys179 and Cys214 (40.3 and 41.5
ppm, respectively) confirmed the presence of the disulfide bond.
Conformations of peptide bonds in X-Pro fragments were deduced
from chemical shifts of Cb and Cc. All peptide bonds were shown
to adopt trans conformation, which was additionally confirmed by
the corresponding cross-peaks in 3D 13C-edited NOESY-HSQC
spectra.
Three-dimensional structure of Q212P mutant
The high number of NOE restrains, together with completeness
of resonance assignments, allowed us to determine the structure of
Q212P mutant with high resolution (Figure 2 and Table 1). The
three-dimensional structure of the Q212P mutant consists of a
Table 1. NMR restrains and structural statistics for the
ensemble of 20 lowest energy structures of HuPrP(90-231,
M129, Q212P) protein.
NOE upper distance limitsa 2205
Intra-residue & sequential (|i-j|#1) 1244
Medium-range (|i-j|,5) 491
Long-range (|i-j|.5) 470
Torsion angle constraintsa
backbone (w/y) 188
r.m.s.d. from idealized covalent geometry
bonds (A˚) 0.0012560.00002
angles (deg) 0.24960.002
impropers (deg) 0.14160.003
r.m.s.d. to the mean coordinates (A˚)
ordered backbone atoms (125..226) 1.0160.34
Ordered heavy atoms (125..226) 1.4560.31
Ramachandran plot (%)b,d
Residues in most favored regions (%) 92.1
Residues in additional allowed regions (%) 7.2
Residues in generously allowed regions (%) 0.4
Residues in disallowed regions 0.3
Structure Z-scoresc,d
1st generation packing quality 23.19860.230
2nd generation packing quality 22.70960.252
Ramachandran plot apperance 22.58460.457
Chi-1/chi-2 rotamer quality 24.09860.386
Backbone conformation 22.87260.444
RMS Z-scoresc,d
Bond lenghts 1.08460.045
Bond angles 0.53960.038
Omega angle restrains 0.76960.042
Side chain planarity 1.12560.200
Improper dihedral distribution 0.88660.067
Inside/Outside distribution 1.00860.008
aNone of the 20 structures exhibits distance violation over 0.2 A˚ and torsion
angle violation over 5u.
bEnsemble of structures was analyzed by PROCHECK-NMR (version 3.4) program
[57].
cEnsemble of structures was validated and analyzed using WhatIF program [58].
dValidation procedure was performed on the structured part from residues 125
to 231.
doi:10.1371/journal.pone.0011715.t001
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well-defined globular domain and highly disordered N-terminal
tail. The C-terminal globular domain (residues 125–231) is
composed of a short anti-parallel b-sheet and four a helices.
A detailed analysis of the structures ensemble, and comparison
to the known structures of PrPC proteins from human and other
mammals, indicated that the substitution of the glutamine by a
proline at the codon 212 resulted in minor if any local structural
changes. The comparison of structural details of a3 helices in
Q212P mutant and WT protein showed small differences with
r.m.s.d. of 0.7 A˚ for backbone atoms between Met205 and Arg220
(Figure 2C). However, the mutation carried notable differences in
the overall structure of C-terminal domain. In particular, while a3
helix is well ordered from residue Glu200 to Arg220, it does not
exhibit properties of a common helical conformation for the
Figure 3. 15N relaxation rates for HuPrP(90–231, M129, Q212P) protein at 298K. 15N longitudinal (R1), transverse (R2) relaxation rates and
heteronuclear {1H}-15N NOE data acquired at 11.7 T and 16.4 T shown in blue and red, respectively.
doi:10.1371/journal.pone.0011715.g003
Figure 4. Distance restrains per residue. (A) Type of NOE used in structure calculations of HuPrP(90–231, M129, Q212P) protein. (B) Enlarged
region between Tyr218 and Tyr225. Glu221 and Ser222 do not exhibit any long-range NOE contacts. (C) Schematic presentation of long-range NOE
contacts (|i-j|.5) between residues in helices a3 and a4. For clarity, only inter-helical NOE contacts are shown.
doi:10.1371/journal.pone.0011715.g004
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subsequent two residues in primary sequence of Q212P mutant.
Glu221 and Ser222 interrupt the regular structure of a3 helix
(Figure 2A). In fact, the region between Glu200 and Tyr226
consists of two helices that are annotated by us as a3 and a4. The
collected NMR relaxation data, together with the low number of
NOE restrains for Glu221 and Ser222, additionally confirmed an
increased mobility, and the disruption of helical conformation at
those positions (Figures 3, 4A and 4B). Medium-range NOE
interactions proved the existence of one turn of a regular a helix
(i.e. a4 helix) within the region from Gln223 to Tyr226.
The observations of long-range NOE contacts amongst residues
Tyr218, Ala224 and Tyr225 in a3 and a4 helices demonstrate
their spatial relationships in the calculated structures (Figure 4C).
The a4 helix exhibits increased molecular mobility that is
evidenced through reduced heteronuclear {1H}-15N NOE values
in combination with increased 15N R1 and reduced
15N R2
relaxation rates (Figure 3).
b2–a2 loop region exposes hydrophobic surface that is
available for intermolecular interactions
One important structural feature of Q212P mutant as opposed
to the WT consists in a different mutual orientation of aromatic
residues in b2–a2 loop (Figures 5A and B). Aromatic residues
Tyr162, Tyr163, Tyr169 and Phe175 are in close contact in the
WT protein thus forming a hydrophobic cluster at the interface of
b2, a2 and a3 structural elements [25]. Within b2–a2 loop region
Tyr169, given its central position, interacts with Tyr163 and
Phe175 in the WT protein (Figure 5B). In contrast, in Q212P
mutant Tyr169 is exposed to solvent resulting highly flexible
(Figures 5A). Different orientation of Tyr169 is coupled with a
marked twist of Phe175 away from the b2–a2 loop. The numerous
NOE-based distance restraints demonstrate that the aromatic ring
of Phe175 is well defined. As a result the whole hydrophobic
cluster is changed and shows increased exposure of hydrophobic
surface of the protein to solvent (Figure 5A). Interestingly, the b2–
a2 loop regions in PrP structures of elk, bank vole and tammar
wallaby display high structural definition (Figure 5). This loop
plasticity may therefore modulate the susceptibility of a given
species to prion disease [32,33,34].
Mutual orientation of a2 and a3 helices
The disulfide bridge involving Cys179 and Cys214 determines
the overall structure of the PrP by fixing the mutual orientation of
a2 and a3 helices. Upon mutation at position 212 the local
topology of a3 helix remained unchanged although Pro is a well
known helix-breaker [42]. However, detailed structural analysis of
the Q212P mutant has revealed that a3 helix exhibits a small
rotation along the helical axis compared to the WT protein. A turn
of a3 helix around Pro212 is altered to accommodate unfavorable
steric interactions of proline with the preceding residue Glu211.
Figure 5. Comparison of local structural variations of different mammalian PrPC from residue Val161 to Cys179 representing b2–a2
loop. (A) HuPrP(90–231, M129, Q212P) (pdb id 2KUN, this work). (B) WT HuPrP(90–231, M129) (pdb id 1QM1) [25]. (C) Elk PrP (pdb id 1XYW) [34]. (D)
Bank vole PrP (pdb id 2K56) [33]. (E) Tammar wallaby PrP (pdb id 2KFL) [32].
doi:10.1371/journal.pone.0011715.g005
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The relative orientation of a3 helix in comparison to the other
secondary structure elements has changed (Figures 6A and 6B).
Our experimental data yielded 59 long-range distance restraints,
which enabled us to determine the mutual orientation of a2 and a3
helices with high accuracy. The large number of restraints evenly
distributed along the inter-helical surface demonstrated that the C-
Figure 6. Structural details of HuPrP(90–231, M129, Q212P) (A, C, E) and WT protein (B, D, F). (A) Carton presentation of a2, a3 and a4
helices with mutual orientation of Phe175 and Gln217 in the Q212P mutant. (B) Carton presentation of a2 and a3 helices with mutual orientation of
Phe175 and Gln217 in the WT protein. (C) The mutual orientation of a2 and a3 helices with indicated inter-helical angle in Q212P mutant. (D) The
mutual orientation of a2 and a3 helices with indicated inter-helical angle in WT protein. (E) Structural organization of b2-a2 loop and a3 and a4 helices
in Q212P mutant. (F) Structural organization of b2-a2 loop and a3 helix in WT protein.
doi:10.1371/journal.pone.0011715.g006
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terminal part of a3 helix formed close contacts with the N-terminal
part of a2 helix (Figure 6A). An illustration of this long-range
interaction is the distance between Cf atom of Phe175 and Cc
atom of Gln217, which is 4.9 A˚. The corresponding distance in
the structure of WT protein is 8.5 A˚ (Figure 6B). The inter-helical
angle between a2 and a3 helices is 33u in the mutant in
comparison to 51u in the WT protein structure (Figures 6C and
D). Simultaneously, the distance between helical axes differs by
1.4 A˚ (Table 2).
In principle, a reliable source of experimental data on relative
orientation of two helices can be obtained by acquiring Residual
Dipolar Couplings (RDC) [43]. Our attempts to prepare an NMR
sample of HuPrP(90–231, M129, Q212P) protein in a stretched
gel though, was unsuccessful due to protein aggregation. Prion
protein exhibits a large hydrophobic surface, which is exposed to
solution and can therefore unspecifically interact with the medium.
In addition, we tried to extract RDC values from NMR IPAP
experiments performed at different magnetic fields [44]. Unfortu-
nately, RDC values obtained for the mutant on the basis of self-
orientation were too small to be used in structure calculations.
Nevertheless, inter-helical angles could be determined with high
accuracy without the use of RDC data [45]. In the Q212P mutant
protein, the high number of long-range NOE contacts between
amino acid residues in a2 and a3 helices provided sufficient
experimental data for defining mutual orientation of the two
helices. On average we observed 6 to 8 long-range distance
restrains per residue at the inter-helical interface (Figure 4).
Discussion
In this study we determined the structure of the HuPrP(90-231,
M129) carrying the Q212P mutation associated to a GSS
syndrome. The high-resolution NMR structure of Q212P mutant
revealed unique structural features compared to the WT protein.
The most remarkable differences involve the C-terminal end of
the protein and the b2–a2 loop region. The structure of Q212P
mutant is the first known example of PrP structure where the a3
helix between Glu200 and Tyr226 is broken into two helices. It is
noteworthy that a break occurs almost two helical turns beyond
Pro212, which is the position of mutation. The break results in
dramatic changes in hydrophobic interactions between a3 helix
and b2–a2 loop region. In the WT protein long-range interactions
between Tyr225 and Met166 define the position of b2–a2 loop,
and thus tertiary structure of the protein (Figure 6F). The
distance between Ca atoms of Tyr 225 and Met166 in structures
of prion proteins of different mammals is typically 8.4 A˚, whereas
it is 16.5 A˚ in the Q212P mutant (Table 3). Longer distance is
correlated with a marked twist of Tyr225 away from b2–a2 loop
(Figure 6E). Tyr225 in Q212P mutant forms hydrophobic
interactions with residues in a3 helix (e.g. Ile215, Table 3).
These interactions define mutual orientation of a3 and a4 helices.
As Tyr225 is unable to form contact with Met166, hydrophobic
cluster is opened and accessible to solvent. Exposure of
hydrophobic surface is tightly correlated with orientation of
aromatic residues Tyr163, Tyr169 and Phe175 in Q212P mutant
(Figure 7A). The opened cleft has been proposed as the binding
site for a hypothetical facilitator of prion conversion that may
play a role in pathogenic PrPSc formation [23,24]. In the WT
protein, the solvent exposed surface of b2–a2 loop and a3 helix
region is smaller and Tyr169 is buried inside the hydrophobic
cluster.
The increased flexibility in the C-terminal part of a3 helix in
PrP mutants has been described before [31,46]. In the
HuPrP(90–231, M129, R220K) artificial mutant for example,
a3 helix is well ordered up to the point mutation (Figure 7B) [31].
After this mutation, a3 helix shows increased flexibility and is less
ordered. At the same time, R220K mutation has not altered the
hydrophobic interactions between aromatic residues of b2–a2
loop and a3 helix (Figure 7B and Table 3). On the other hand,
the structure of CJD-related mutant HuPrP(90-231, M129,
E200K) has revealed features in b2–a2 loop region similar to
the Q212P mutant (Figure 7C) [28]. In E200K variant, Tyr169 is
exposed to solvent and shows increased flexibility. The remaining
aromatic residues in b2–a2 loop (Tyr163 and Phe175) form a
hydrophobic cluster through interaction with Tyr218 and Tyr225
in a3 helix (Figures 7C). The effects of both Q212P and R220K
mutations in terms of unstructured C-terminal parts of proteins
are comparable (Figures 7A and B). In support, recently
published crystal structures of the pathological HuPrP(90–231,
D178N, M/V129) and HuPrP(90–231, F198S, M/V129) mu-
tants demonstrated similar orientations of Tyr169 outside the
globular part [46].
Mutations in HuPrP segregating with familial TSE may provoke
reduced stability in the structure of the PrPC form. This event
could enhance the tendency of PrPC to adopt different conforma-
tional states, some of which would then lead to the conversion into
the PrPSc isoform [41]. It is noteworthy that HuPrP carrying either
D178N or F198S mutations actually showed a reduced thermo-
dynamic stability compared to the WT HuPrP [16].
The biological implications of our findings could provide new
clues to our understanding of the structural changes occurring in
PrPC during prion formation. Special interest in prion biology is
focused on the epitope formed by the b2–a2 loop and the a3 helix,
because it seems to modulate specific intermolecular contacts
involved in the development of TSE. In the case of Q212P mutant
it is possible to argue that the larger solvent exposure of this
Table 2. Inter-helical angles and distances between helices
a2 and a3 in high-resolution structures of PrP
C proteins a.
pdb id Angle (u) Distance (A˚)
HuPrP(90–231, M129, Q212P) 2KUN 33.1 8.4
HuPrP(90-231, M129) 1QM1 [25] 50.9 7.0
Elk PrPC 1XYW [34] 47.9 7.7
Bank vole PrPC 2K56 [33] 45.6 8.0
Tammar wallaby PrPC 2KFL [32] 52.6 6.9
aCalculated with Chimera system [59].
doi:10.1371/journal.pone.0011715.t002
Table 3. Distances between Tyr225 and residues within b2–a2
loop region and a3 helix.
PrPC Y169–Y225 a,b M166–Y225 a,c I215–Y225 a,d
HuPrP(90–231) 14.161.2 8.460.6 19.260.6
HuPrP(90–231, Q212P) 18.862.0 16.561.6 9.961.1
HuPrP(90–231, E200K) 11.761.4 8.460.5 19.260.5
HuPrP(90–231, R220K) 13.360.9 8.460.5 19.961.0
aAll presented data are average distances and standard deviations in A˚
calculated for ensemble of 20 structures deposited in pdb.
bDistances between carbons Tyr169 Ca and Tyr225 Ca.
cDistances between carbons Met166 Ca and Tyr225 Ca.
dDistances between carbons Ile215 Cd1 and Tyr225 Cz.
doi:10.1371/journal.pone.0011715.t003
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epitope causes an altered interaction with other, yet unknown,
cellular cofactors, chaperones, or PrPC ligands. Recent NMR
studies provide evidences that some GSS mutations increase the
affinity of the PrP for binding lipid structures [47]. The altered
conformation observed in the Q212P mutant might cause a
different affinity for cellular membranes and, consequently, an
Figure 7. Structural comparison of HuPrP mutants. (A) Structural details of b2a2a3a4 region (161–228) of 20 lowest energy structures for
HuPrP(90–231, M129, Q212P) mutant. (B) Structural details of b2a2a3 region (161–228) of 20 lowest energy structures for HuPrP(90–231, M129, R220K)
(pdb id 1E1U) mutant [31]. (C) Structural details of b2a2a3 region (161–228) of 20 lowest energy structures for HuPrP(90–231, M129, E200K) (pdb id
1FO7) mutant [28]. In all three panels the point mutation is indicated in magenta (left). Top view of the hydrophobic core composed of aromatic
amino acid residues (center). Hydrophobicity surface is presented on the right, where red color indicates hydrophobic and blue color represents
hydrophilic surface.
doi:10.1371/journal.pone.0011715.g007
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aberrant localization of PrP in the cell compartments, to favor
formation of altered ER topologies [20,21]. Independent
evidences derived from cell culture expressing the mutant
Q212P showed that this point mutation affects folding and
maturation of PrPC in the secretory pathway of neuronal cells
[19,22]. These authors investigated the generation and the
turnover of Q212P and others mutants in mouse neuroblastoma
N2a cells discovering an intracellular post ER control pathway
that selectively routes aberrant PrP species to the lysosomes [48].
The structure-function relationship suggested with our work could
provide a biological basis for understanding the spontaneous
generation of PrPSc in inherited prion disease.
Materials and Methods
Plasmid Construction
The Q212P mutant was constructed using the QuikChangeTM
kit (Stratagene) utilizing primers 59-CGC GTG GTT GAG CCG
ATG TGT ATC ACC C-39 and 59- GGG TGA TAC ACA TCG
GCT CAA CCA CGC G -39 and HuPrP(90-231, M129) as
template. The DNA product was then inserted into a pET-11a
vector (Novagen) containing a His-tag sequence at the carboxy-
terminus of the inserted sequence. The cloned DNA sequences
were verified by sequencing.
Protein Expression and Purification
Freshly transformed overnight culture of E. coli BL21 (DE3)
cells (Stratagene) was added at 37uC to 2 L of minimal medium
(MM) plus ampicillin (100 mg/mL). For isotope labeling 4 g/L
[13C6] glucose and 1 g/L [
15N] ammonium chloride were added.
At 0.8 OD600 expression was induced with isopropyl b-D-
galactopyranoside to a final concentration of 0.8 mM. The cells
were harvested 12 h after induction. The cells were lysed by a
French press (EmulsiFlex-C3) and the inclusion bodies were
washed in buffer containing 25 mM Tris-HCl, 5 mM EDTA,
0.8% TritonX100, pH 8, and then in bi-distilled water several
times. Pure inclusion bodies were solubilized in 5 volumes of 6 M
GndHCl, loaded onto a 5 mL HisTrap column (GE Healthcare)
equilibrated in binding buffer (2 M GndHCl, 500 mM NaCl,
20 mM TrisHCl, 20 mM imidazole, pH 8) and eluted with
500 mM imidazole. Subsequently, the protein was purified by
reverse-phase (Jupiter C4, 250 mm621.2 mm, 300 A˚ pore size,
Phenomenex) and separated using a gradient of 0-95%
acetonitrile and 0.1% trifluoroacetic acid. The purified protein
was lyophilized and dissolved in 8 M GndHCl. Refolding was
performed by dialysis against refolding buffer (20 mM sodium
acetate-d3, 0.005% NaN3, pH 5.5) using a Spectrapor-membrane
(MW 3000). Purified protein was analyzed by SDS-polyacryla-
mide gel electrophoresis under reducing condition, western blot,
and electrospray mass spectroscopy.
NMR spectroscopy
All NMR experiments used for structure calculation were
performed on 13C, 15N double labeled HuPrP(90-231, M129,
Q212P) protein on Varian VNMRS 800 MHz NMR spectro-
meter using triple 1H/13C/15N resonance cold probe-head with
inverse detection at 298 K. NMR sample consisted in a 0.8 mM
concentration of 13C, 15N-labeled protein in sodium acetate buffer.
NMR experiments with detection of HN were performed in 90%/
10% H2O/
2H2O, pH 5.5. HC detected NMR datasets were
acquired in 100% deuterated buffer. Relaxation measurements
including 15N longitudinal (R1), transversal (R2) relaxation rates
and {1H}-15N NOE were performed on two magnetic fields of
11.7 T and 16.4 T. Standard triple resonance NMR experiments
were used for assignments and to obtain distance restraints.
Chemical shifts were referenced considering external DSS. All
recorded spectra were processed by NMRPipe software [49] and
analyzed with Sparky [50] and CARA software (available for free
download from http://www.nmr.ch) [51].
Structure calculations
The initial structure calculations were done by program
CYANA 2.1 [52]. The automatic NOE assignment procedure
[53] yielded 2205 distance constraints which were imported into
CNS (version 1.2) software [54,55] for structural refinement. High
resolution 3D structure of Q212P mutant was determined based
on 1244 intra- and sequential, 491 short-range and 470 long-range
distance constraints supported by 188 backbone torsion angle
restraints (Table 1). Finally, the structure refinement was
performed using explicit solvent model in YASARA program
suite (www.yasara.org) [56]. The final ensemble of 20 lowest
energy structures exhibited good convergence and very high
definition. Validation procedure using PROCHECK-NMR [57]
and WhatIF [58] programs demonstrated that the final family of
3D structures agreed with the distance restrains and offered good
geometry and side chain packing.
Acknowledgments
The authors wish to thank Dr. Chris Spronk (Spronk NMR Consultancy;
www.spronknmr.eu) for his assistance in structure refinement and
validation, and to anonymous reviewer for the valuable comments, which
helped us improve the quality of the reported structure. The authors would
also like to thank Gabriella Furlan for editing and proofreading the
manuscript.
Author Contributions
Conceived and designed the experiments: JP IZ GL. Performed the
experiments: GI GG MJ ŁJ. Analyzed the data: GI GG MJ J FB JP IZ GL.
Contributed reagents/materials/analysis tools: GG. Wrote the paper: GI
GG GL.
References
1. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95: 13363–13383.
2. Aguzzi A, Sigurdson C, Heikenwaelder M (2008) Molecular mechanisms of
prion pathogenesis. Annu Rev Pathol 3: 11–40.
3. Kuwata K, Li H, Yamada H, Legname G, Prusiner SB, et al. (2002) Locally
disordered conformer of the hamster prion protein: a crucial intermediate to
PrPSc? Biochemistry 41: 12277–12283.
4. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, et al. (1991) Secondary
Structure-Analysis of the Scrapie-Associated Protein Prp 27-30 in Water by
Infrared-Spectroscopy. Biochemistry 30: 7672–7680.
5. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, et al. (1993) Conversion of
Alpha-Helices into Beta-Sheets Features in the Formation of the Scrapie Prion
Proteins. Proc Natl Acad Sci USA 90: 10962–10966.
6. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, et al. (1993) Mice
devoid of PrP are resistant to scrapie. Cell 73: 1339–1347.
7. Fischer M, Rulicke T, Raeber A, Sailer A, Moser M, et al. (1996) Prion protein
(PrP) with amino-proximal deletions restoring susceptibility of PrP knockout
mice to scrapie. Embo J 15: 1255–1264.
8. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, et al. (2004)
Synthetic mammalian prions. Science 305: 673–676.
9. Legname G, Nguyen HO, Baskakov IV, Cohen FE, Dearmond SJ, et al. (2005)
Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad
Sci U S A 102: 2168–2173.
10. Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, et al. (2002)
Mutations of the prion protein gene phenotypic spectrum. J Neurol 249:
1567–1582.
11. Chiesa R, Piccardo P, Ghetti B, Harris DA (1998) Neurological illness in
transgenic mice expressing a prion protein with an insertional mutation. Neuron
21: 1339–1351.
Mol. Basis of Prion Disease
PLoS ONE | www.plosone.org 10 July 2010 | Volume 5 | Issue 7 | e11715
12. Dossena S, Imeri L, Mangieri M, Garofoli A, Ferrari L, et al. (2008) Mutant
prion protein expression causes motor and memory deficits and abnormal sleep
patterns in a transgenic mouse model. Neuron 60: 598–609.
13. Hsiao KK, Groth D, Scott M, Yang SL, Serban H, et al. (1994) Serial
transmission in rodents of neurodegeneration from transgenic mice expressing
mutant prion protein. Proc Natl Acad Sci U S A 91: 9126–9130.
14. Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, et al. (1990)
Spontaneous neurodegeneration in transgenic mice with mutant prion protein.
Science 250: 1587–1590.
15. Apetri AC, Surewicz K, Surewicz WK (2004) The effect of disease-associated
mutations on the folding pathway of human prion protein. J Biol Chem 279:
18008–18014.
16. Liemann S, Glockshuber R (1999) Influence of amino acid substitutions related
to inherited human prion diseases on the thermodynamic stability of the cellular
prion protein. Biochemistry 38: 3258–3267.
17. Swietnicki W, Petersen RB, Gambetti P, Surewicz WK (1998) Familial
mutations and the thermodynamic stability of the recombinant human prion
protein. J Biol Chem 273: 31048–31052.
18. Vanik DL, Surewicz WK (2002) Disease-associated F198S mutation increases
the propensity of the recombinant prion protein for conformational conversion
to scrapie-like form. J Biol Chem 277: 49065–49070.
19. Ashok A, Hegde RS (2009) Selective processing and metabolism of disease-
causing mutant prion proteins. PLoS Pathog 5: e1000479.
20. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, et al. (1998) A
transmembrane form of the prion protein in neurodegenerative disease. Science
279: 827–834.
21. Heske J, Heller U, Winklhofer KF, Tatzelt J (2004) The C-terminal globular
domain of the prion protein is necessary and sufficient for import into the
endoplasmic reticulum. J Biol Chem 279: 5435–5443.
22. Mishra RS, Bose S, Gu Y, Li R, Singh N (2003) Aggresome formation by
mutant prion proteins: the unfolding role of proteasomes in familial prion
disorders. J Alzheimers Dis 5: 15–23.
23. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, et al. (1997)
Evidence for protein X binding to a discontinuous epitope on the cellular prion
protein during scrapie prion propagation. Proc Natl Acad Sci USA 94:
10069–10074.
24. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, et al. (1995) Prion
propagation in mice expressing human and chimeric PrP transgenes implicates
the interaction of cellular PrP with another protein. Cell 83: 79–90.
25. Zahn R, Liu AZ, Lu¨hrs T, Riek R, von Schroetter C, et al. (2000) NMR solution
structure of the human prion protein. Proc Natl Acad Sci USA 97: 145–150.
26. Zahn R, vonSchroetter C, Wu¨thrich K (1997) Human prion proteins expressed
in Escherichia coli and purified by high-affinity column refolding. FEBS Lett
417: 400–404.
27. Bae SH, Legname G, Serban A, Prusiner SB, Wright PE, et al. (2009) Prion
proteins with pathogenic and protective mutations show similar structure and
dynamics. Biochemistry 48: 8120–8128.
28. Zhang YB, Swietnicki W, Zagorski MG, Surewicz WK, So¨nnichsen FD (2000)
Solution structure of the E200K variant of human prion protein - Implications
for the mechanism of pathogenesis in familial prion diseases. J Biol Chem 275:
33650–33654.
29. Piccardo P, Dlouhy SR, Lievens PMJ, Young K, Thomas DP, et al. (1998)
Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated
with prion protein heterogeneity. J Neuropathol Exp Neurol 57: 979–988.
30. Young K, Piccardo P, Kish SJ, Ang LC, Dlouhy S, et al. (1998) Gerstmann-
Stra¨ussler-Scheinker disease (GSS) with a mutation at prion protein (PrP) residue
212. J Neuropathol Exp Neurol 57: 518.
31. Calzolai L, Lysek DA, Gu¨ntert P, von Schroetter C, Riek R, et al. (2000) NMR
structures of three single-residue variants of the human prion protein. Proc Natl
Acad Sci USA 97: 8340–8345.
32. Christen B, Hornemann S, Damberger FF, Wu¨thrich K (2009) Prion Protein
NMR Structure from Tammar Wallaby (Macropus eugenii) Shows that the
beta2-alpha2 Loop Is Modulated by Long-Range Sequence Effects. J Mol Biol
389: 833–845.
33. Christen B, Pe´rez DR, Hornemann S, Wu¨thrich K (2008) NMR Structure of the
Bank Vole Prion Protein at 20 degrees C Contains a Structured Loop of
Residues 165-171. J Mol Biol 383: 306–312.
34. Gossert AD, Bonjour S, Lysek DA, Fiorito F, Wu¨thrich K (2005) Prion protein
NMR structures of elk and of mouse/elk hybrids. Proc Natl Acad Sci USA 102:
646–650.
35. Lopez Garcia F, Zahn R, Riek R, Wuthrich K (2000) NMR structure of the
bovine prion protein. Proc Natl Acad Sci USA 97: 8334–8339.
36. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, et al. (1996) NMR
structure of the mouse prion protein domain PrP(121–321). Nature 382:
180–182.
37. Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, et al. (1995)
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and
other human spongiform encephalopathies (prion diseases). Brain Pathol 5:
459–466.
38. Liberski PP, Budka H (2004) Gerstmann-Straussler-Scheinker disease. I. Human
diseases. Folia Neuropathol 42 Suppl B: 120–140.
39. Liberski PP, Jaskolski M, Brown P (2004) Gerstmann-Straussler-Scheinker
disease. II. An effect of GSS mutation on PRP structure. Folia Neuropathol 42
Suppl B: 140–152.
40. Wopfner F, Weidenhofer G, Schneider R, von Brunn A, Gilch S, et al. (1999)
Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible
regions of the prion protein. J Mol Biol 289: 1163–1178.
41. Riek R, Wider G, Billeter M, Hornemann S, Glockshuber R, et al. (1998) Prion
protein NMR structure and familial human spongiform encephalopathies. Proc
Natl Acad Sci USA 95: 11667–11672.
42. Macarthur MW, Thornton JM (1991) Influence of Proline Residues on Protein
Conformation. J Mol Bio 218: 397–412.
43. Lipsitz RS, Tjandra N (2004) Residual dipolar couplings in NMR structure
analysis. Annual Review of Biophysics and Biomolecular Structure 33: 387–413.
44. Yao LS, Ying JF, Bax A (2009) Improved accuracy of N-15-H-1 scalar and
residual dipolar couplings from gradient-enhanced IPAP-HSQC experiments on
protonated proteins. Journal of Biomolecular Nmr 43: 161–170.
45. Rustandi RR, Baldisseri DM, Inman KG, Nizner P, Hamilton SM, et al. (2002)
Three-dimensional solution structure of the calcium-signaling protein Apo-
S100Al as determined by NMR. Biochemistry 41: 788–796.
46. Lee S, Antony L, Hartmann R, Knaus KJ, Surewicz K, et al. (2009)
Conformational diversity in prion protein variants influences intermolecular
beta-sheet formation. Embo J 29: 251–262.
47. Hornemann S, von Schroetter C, Damberger FF, Wu¨thrich K (2009) Prion
Protein-Detergent Micelle Interactions Studied by NMR in Solution. J Biol
Chem 284: 22713–22721.
48. Borchelt DR, Taraboulos A, Prusiner SB (1992) Evidence for Synthesis of
Scrapie Prion Proteins in the Endocytic Pathway. J Biol Chem 267:
16188–16199.
49. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a
multidimensional spectral processing system based on UNIX pipes. J Biomol
NMR 6: 277–293.
50. Goddard TD, Kneller DG, SPARKY 3. University of California, San
Francisco.
51. Keller R (2004) The Computer Aided Resonance Assignment Tutorial:
CANTINA Verlag.
52. Gu¨ntert P, Mumenthaler C, Wu¨thrich K (1997) Torsion angle dynamics for
NMR structure calculation with the new program DYANA. J Mol Biol 273:
283–298.
53. Herrmann T, Gu¨ntert P, Wu¨thrich K (2002) Protein NMR structure
determination with automated NOE assignment using the new software
CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol
319: 209–227.
54. Bru¨nger AT (2007) Version 1.2 of the Crystallography and NMR system. Nat
Protoc 2: 2728–2733.
55. Bru¨nger AT, Adams PD, Clore GM, DeLano WL, Gros P, et al. (1998)
Crystallography & NMR system: A new software suite for macromolecular
structure determination. Acta Crystallogr D Biol Crystallogr 54: 905–921.
56. Krieger E, Koraimann G, Vriend G (2002) Increasing the precision of
comparative models with YASARA NOVA - a self-parameterizing force field.
Proteins: Struct Funct Genet 47: 393–402.
57. Laskowski RA, Rullmann JAC, MacArthur MW, Kaptein R, Thornton JM
(1996) AQUA and PROCHECK-NMR: Programs for checking the quality of
protein structures solved by NMR. J Biomol NMR 8: 477–486.
58. Vriend G (1990) What If - a Molecular Modeling and Drug Design Program.
J Mol Graph 8: 52–56.
59. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al.
(2004) UCSF chimera - A visualization system for exploratory research and
analysis. J Comput Chem 25: 1605–1612.
Mol. Basis of Prion Disease
PLoS ONE | www.plosone.org 11 July 2010 | Volume 5 | Issue 7 | e11715
